# Abstracts of the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting **Authors:** Alexi Campbell, Sharlene Gill, Desirée Hao, Suneil Khanna, Erin Powell, Moira Rushton, Maryam Soleimani, Stephen Welch PMC · DOI: 10.3390/curroncol32020105 · 2025-02-12 ## TL;DR This document presents the abstracts from the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting held in Ottawa. ## Contribution The contribution is the compilation and presentation of 24 selected research abstracts from the 2024 meeting. ## Key findings - Twenty-four abstracts were selected for presentation as oral or poster presentations. - Awards were given to the top three abstracts, marked as 'Award Recipient'. ## Abstract On behalf of the Canadian Association of Medical Oncologists, we are pleased to present the abstracts of the 2024 Annual Scientific Meeting. The CAMO Annual Scientific Meeting (ASM) took place from 24–26 October 2024 in an in-person event in Ottawa, ON. Twenty-four (24) abstracts were selected for presentation as oral presentations and poster presentations. Awards for the top three (3) abstracts were presented during the ASM; they have been marked as “Award Recipient”. We congratulate all presenters on their research work and contribution. ## Full-text entities - **Genes:** NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, NBN (nibrin) [NCBI Gene 4683] {aka AT-V1, AT-V2, ATV, NBS, NBS1, P95}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, DLAT (dihydrolipoamide S-acetyltransferase) [NCBI Gene 1737] {aka DLTA, E2, PBC, PDC-E2, PDCE2}, FANCA (FA complementation group A) [NCBI Gene 2175] {aka FA, FA-H, FA1, FAA, FACA, FAH}, TXK (TXK tyrosine kinase) [NCBI Gene 7294] {aka BTKL, PSCTK5, PTK4, RLK, TKL}, DPYD (dihydropyrimidine dehydrogenase) [NCBI Gene 1806] {aka DHP, DHPDHASE, DPD, DYPD}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, PALB2 (partner and localizer of BRCA2) [NCBI Gene 79728] {aka BROVCA5, FANCN, PNCA3}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, SPOP (speckle type BTB/POZ protein) [NCBI Gene 8405] {aka BTBD32, NEDMACE, NEDMIDF, NSDVS1, NSDVS2, TEF2}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, CDK12 (cyclin dependent kinase 12) [NCBI Gene 51755] {aka CRK7, CRKR, CRKRS}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep} - **Diseases:** ET (MESH:D004700), ATS (MESH:D000088562), Breast Cancer (MESH:D001943), injury to people or property (MESH:C000719191), I. (MESH:D006969), laryngeal cancer (MESH:D007822), oral cavity cancer (MESH:D009062), metastatic disease (MESH:D000092182), PMS2 deficiency (MESH:D007153), stage III disease (MESH:D007676), Genito-Urinary Malignancies (MESH:D014565), HNSCC (MESH:D000077195), renal cell carcinoma (MESH:D002292), pancreatic and brain cancers (MESH:D010190), COVID-19 (MESH:D000086382), R/M (MESH:C566367), lung (MESH:D008171), OMD (MESH:D004194), hypertension (MESH:D006973), BrM (MESH:D001932), CRC (MESH:D015179), OP (MESH:D009959), Death (MESH:D003643), Brain Metastasis (MESH:D009362), lymphatic metastasis (MESH:D008207), Melanoma (MESH:D008545), cutaneous melanoma (MESH:C562393), Metastatic Renal Cell Carcinoma (MESH:C538445), TNBC (MESH:D064726), Infectious Diseases (MESH:D003141), Cancer (MESH:D009369), cardiac (MESH:D006331), -advanced rectal cancer (MESH:D012004), BCLC (MESH:D006528), bladder cancer (MESH:D001749), adenocarcinoma (MESH:D000230), lung, lymphoma (MESH:D008223), GLR (MESH:D008175), ALBI (MESH:D007647), Signet (MESH:D018279), OFS (MESH:D010051), AI (MESH:C537436), mismatch repair- (MESH:C536928), Castrate (MESH:D064129), PC (MESH:D011471), NSCLC (MESH:D002289), CTN (MESH:D000075902), C (OMIM:211750), burnout (MESH:D002055), Neuro-Oncology (MESH:D000072716), gastrointestinal cancer (MESH:D005770), Kidney Cancer (MESH:D007680), stage IIB/C (MESH:D062706), cardiotoxicity (MESH:D066126), ICIs (MESH:D054179), squamous cell carcinoma (MESH:D002294), breast (MESH:D061325), Toxicities (MESH:D064420), III/ (MESH:C537189), peritoneal metastasis (MESH:D010538) - **Chemicals:** Radium-223 (MESH:C000615150), trastuzumab (MESH:D000068878), FOLFOX (MESH:C410216), bilirubin (MESH:D001663), denosumab (MESH:D000069448), carboplatin (MESH:D016190), cephalosporins (MESH:D002511), alcohol (MESH:D000438), atezolizumab (MESH:C000594389), Durvalumab (MESH:C000613593), cisplatin (MESH:D002945), bevacizumab (MESH:D000068258), anthracycline (MESH:D018943), zoledronate (MESH:D000077211), sorafenib (MESH:D000077157), 1L TKI (-), Abemaciclib (MESH:C000590451), tremelimumab (MESH:C520704), penicillins (MESH:D010406), calcium (MESH:D002118), fluoroquinolones (MESH:D024841), lenvatinib (MESH:C531958) - **Species:** Homo sapiens (human, species) [taxon 9606] - **Mutations:** V600E, L858R --- Source: https://tomesphere.com/paper/PMC11854492